Glucose-lowering drug use and new-onset atrial fibrillation in patients with diabetes mellitus

被引：0

作者：

Gregoire Fauchier

Arnaud Bisson

Alexandre Bodin

Julien Herbert

Denis Angoulvant

Pierre Henri Ducluzeau

Gregory Y. H. Lip

Laurent Fauchier

机构：

[1] Université de Tours,Service de Médecine Interne, Unité d’Endocrinologie Diabétologie et Nutrition, Centre Hospitalier Universitaire et Faculté de Médecine

[2] Université de Tours,Service de Cardiologie, Centre Hospitalier Universitaire et Faculté de Médecine

[3] Université de Tours,Service d’information Médicale, d’épidémiologie et d’économie de la santé, Centre Hospitalier Universitaire et Faculté de Médecine, EA7505

[4] EA4245 T2i,Liverpool Centre for Cardiovascular Science

[5] Université de Tours,Department of Clinical Medicine

[6] INRAE (Institut National de Recherche pour l’Agriculture,undefined

[7] l’Alimentation et l’Environnement),undefined

[8] Unité Mixte de Recherche Physiologie de la Reproduction et des Comportements,undefined

[9] University of Liverpool and Liverpool Heart & Chest Hospital,undefined

[10] Aalborg University,undefined

来源：

Diabetologia | 2021年 / 64卷

关键词：

Atrial fibrillation; DPP4 inhibitors; GLP1 analogues; Insulin; Metformin; Sulfonylureas;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：2602 / 2605

页数：3

共 28 条

[1]

Bisson A(2021)Sex, age, type of diabetes and incidence of atrial fibrillation in patients with diabetes mellitus: a nationwide analysis Cardiovasc Diabetol 20 24-1538

[2]

Bodin A(2019)Risk factors for atrial fibrillation in people with type 1 diabetes: an observational cohort study of 36,258 patients from the Swedish national diabetes registry Diabetes Care 42 1530-1115

[3]

Fauchier G(2019)Atrial fibrillation and diabetes mellitus: JACC review topic of the week J Am Coll Cardiol 74 1107-804

[4]

Hallström S(2019)No evidence of a causal association of type 2 diabetes and glucose metabolism with atrial fibrillation Diabetologia 62 800-undefined

[5]

Pivodic A(2018)Antihyperglycemic drugs use and new-onset atrial fibrillation: A population-based nested case control study PLoS One 13 e0197245-undefined

[6]

Rosengren A(2017)Dipeptidyl peptidase-4 inhibitor decreases the risk of atrial fibrillation in patients with type 2 diabetes: a nationwide cohort study in Taiwan Cardiovasc Diabetol 16 159-undefined

[7]

Ólafsdóttir AF(2020)SGLT2 inhibitors and atrial fibrillation in type 2 diabetes: a systematic review with meta-analysis of 16 randomized controlled trials Cardiovasc Diabetol 19 130-undefined

[8]

Svensson AM(undefined)undefined undefined undefined undefined-undefined

[9]

Lind M(undefined)undefined undefined undefined undefined-undefined

[10]

Wang A(undefined)undefined undefined undefined undefined-undefined

← 1 2 3 →